Clinical Trial Update: Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating zanzalintinib in combination with paclitaxel for recurrent high-grade uterine cancer, and the study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Uterine Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Zanzalintinib (Zanzalintinib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Uterine Cancer, Endometrial Cancer | Phase 1 | Status: RECRUITING